Expression of CD44 splice variants in colorectal cancer
- 1 March 1997
- journal article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 84 (3) , 363-367
- https://doi.org/10.1002/bjs.1800840328
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cellsBMJ, 1994
- Expression of CD44R1 adhesion molecule in colon carcinomas and metastasesThe Lancet, 1993
- Prevention of tumor metastasis formation by anti-variant CD44.The Journal of Experimental Medicine, 1993
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.Proceedings of the National Academy of Sciences, 1992
- Significance of CD44 gene products for cancer diagnosis and disease evaluationThe Lancet, 1992
- Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.Journal of Clinical Investigation, 1991
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- CD44 — A molecule involved in leukocyte adherence and T-cell activationImmunology Today, 1989
- A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in manEuropean Journal of Immunology, 1986